Pfizer has partnered with a ‘computation-driven’ pharmaceutical technology company to develop a drug discovery platform powered by artificial intelligence (AI). Its collaboration with ...

“If I had asked people what they wanted, they would have said faster horses.” This quote, often linked to Henry Ford (though its authenticity is debated), has become a go-to argument for ...

On 11th February, pharmaphorum was invited by Curia to attend a parliamentary roundtable focussed on women’s health, held at the House of Commons and hosted in collaboration with Members of ...

Randall Bateman, MD, Charles F and Joanne Knight Distinguished Professor of Neurology at WashU Medicine. A study of Roche's anti-amyloid drug gantenerumab has suggested that early treatment to ...

The IMPACCT Real World Evidence Summit is back, offering the opportunity to bring together 50+ pharma RWE decision makers to discuss integrated evidence plans, data sharing optimization ...

The study compared CGM to regular fingerprick testing on blood glucose readings after consuming commercial or home-made smoothies or a glucose drink as a control. There has been a major increase ...

In some ways, pharma connecting directly with patients isn’t novel at all: pharma companies in the United States have been ...

This kind of voluntary information that customers share directly with advertisers is known as zero-party data – and it has ...

The idea of direct-to-patient channels in pharma conjures up services like Lilly Direct and PfizerForAll. But ...

Digital pathology specialist Paige has been awarded breakthrough device status from the FDA for an artificial intelligence ...

MoonLake Immunotherapeutics has secured up to $500 million in non-dilutive financing from Hercules Capital, bolstering its ...

Lilly is the third company to partner with Sangamo on STAC-BBB after Astellas Gene Therapies, which paid $20 million upfront ...